Labor induction has contributing factor postterm pregnancy
Postterm pregnancy, i.e. if the pregnancy has gone past the end of the 42nd week.
Intrauterine fetal growth restriction (IUGR).
There are health risks to the woman in continuing the pregnancy (e.g. she has pre-eclampsia).
Premature rupture of the membranes (PROM); this is when the membranes have ruptured, but labor does not start within a specific amount of time.
Premature termination of the pregnancy (abortion).
Fetal death in utero and previous history of stillbirth.
Twin pregnancy continuing beyond 38 weeks.
Previous health conditions that puts risk on the woman and/or her child such as diabetes, high blood pressure
High BMIInduction of labor in those who are either at or after term improves outcomes for newborns and decreases the number of C-sections performed.Criticisms of induction
Induced labor may be more painful for the woman as one of the side effects of intravenous oxytocin is increased contraction pains, mainly due to the rigid onset. This may lead to the increased use of analgesics and other pain-relieving pharmaceuticals. These interventions may also lead to an increased likelihood of caesarean section delivery for the baby. However, studies into this matter show differing results. One study indicated that while overall caesarean section rates from 1990 to 1997 remained at or below 20 per cent, elective induction was associated with a doubling of the rate of Caesarean section. Another study showed that elective induction in women who were not post-term increased a woman's chance of a C-section by two to three times. A more recent study indicated that induction may increase the risk of caesarean section if performed before the 40th week of gestation, but it has no effect or actually lowers the risk if performed after the 40th week.A 2014 systematic review and meta analysis on the subject of induction and its effect on cesarean section indicate that after 41 weeks of gestation there is a reduction of cesarean deliveries when the labour is induced.The Institute for Safe Medication Practices labeled pitocin a "high-alert medication" because of the high likelihood of "significant patient harm when it is used in error."
is caused by results from is influenced by is a factor in contributes to